Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 2,671 | 1,785 | 1,808 | 1,828 | 1,938 |
| Cost of Goods | 1,906 | 2,389 | 1,404 | 1,361 | 1,357 |
| Gross Profit | 765 | -604 | 404 | 467 | 581 |
| Operating Expenses | 5,658 | 4,210 | 3,292 | 3,225 | 2,773 |
| Operating Income | -3,988 | -4,425 | -2,484 | -2,398 | -1,835 |
| Interest Expense | 8 | 8 | 8 | 8 | 8 |
| Other Income | 1 | 1 | 0 | 0 | 0 |
| Pre-tax Income | -3,994 | -4,432 | -2,491 | -2,405 | -1,843 |
| Net Income Continuous | -3,994 | -4,432 | -2,491 | -2,405 | -1,843 |
| Net Income | $-3,994 | $-4,432 | $-2,491 | $-2,405 | $-1,843 |
| EPS Basic Total Ops | -0.12 | -0.15 | -0.12 | -0.09 | -0.09 |
| EPS Basic Continuous Ops | -0.13 | -0.16 | -0.10 | -0.10 | -0.09 |
| EPS Diluted Total Ops | -0.12 | -0.15 | -0.12 | -0.09 | -0.09 |
| EPS Diluted Continuous Ops | -0.13 | -0.16 | -0.10 | -0.10 | -0.09 |
| EBITDA(a) | $-3,903 | $-4,336 | $-2,388 | $-2,298 | $-1,732 |